$FRZT
Freeze Tag, Inc.

2023 Q2 Form 10-Q Financial Statement

#000147793223003597 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $579.5K $511.4K $534.0K
YoY Change 17.62% -0.88% -4.57%
Cost Of Revenue $88.57K $104.8K $92.40K
YoY Change 5.22% 16.12% 25.14%
Gross Profit $491.0K $406.6K $441.6K
YoY Change 20.17% -4.49% -9.09%
Gross Profit Margin 84.72% 79.51% 82.7%
Selling, General & Admin $454.1K $442.9K $384.5K
YoY Change 5.91% 1.51% -4.72%
% of Gross Profit 92.5% 108.92% 87.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $21.17K $2.330K $3.220K
YoY Change -19.84% -90.89% -87.46%
% of Gross Profit 4.31% 0.57% 0.73%
Operating Expenses $454.1K $442.9K $384.5K
YoY Change 5.91% 1.51% -4.72%
Operating Profit $36.85K -$36.29K $57.07K
YoY Change -282.11% 242.34% -30.53%
Interest Expense $11.64K $11.56K -$11.78K
YoY Change -0.59% -4.08% -4.15%
% of Operating Profit 31.6% -20.64%
Other Income/Expense, Net -$11.64K -$11.56K
YoY Change -107.07% -48.97%
Pretax Income $25.20K -$47.84K $45.29K
YoY Change -82.56% 111.21% -35.16%
Income Tax $1.560K
% Of Pretax Income 3.44%
Net Earnings $25.20K -$47.84K $43.73K
YoY Change -82.56% 111.25% -36.07%
Net Earnings / Revenue 4.35% -9.36% 8.19%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 75.06M shares 75.06M shares 75.06M shares
Diluted Shares Outstanding 306.1M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $600.5K $664.7K $741.2K
YoY Change -16.97% -10.64% -1.55%
Cash & Equivalents $600.5K $664.7K $741.2K
Short-Term Investments
Other Short-Term Assets $11.99K $7.860K $13.46K
YoY Change -14.36% -52.16% 7.85%
Inventory
Prepaid Expenses
Receivables $25.61K $17.06K $16.88K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $638.1K $689.7K $771.5K
YoY Change -15.04% -11.04% -0.9%
LONG-TERM ASSETS
Property, Plant & Equipment $15.54K $17.87K $20.20K
YoY Change -40.1% -39.37% -37.22%
Goodwill
YoY Change
Intangibles $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Investments
YoY Change
Other Assets $850.00 $853.00 $371.5K
YoY Change -99.68% -99.65% 78.66%
Total Long-Term Assets $517.6K $450.3K $391.7K
YoY Change 64.67% 43.12% 27.66%
TOTAL ASSETS
Total Short-Term Assets $638.1K $689.7K $771.5K
Total Long-Term Assets $517.6K $450.3K $391.7K
Total Assets $1.156M $1.140M $1.163M
YoY Change 8.48% 4.6% 7.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $162.4K $175.6K $164.5K
YoY Change 2.48% 11.22% 17.27%
Accrued Expenses $500.7K $502.1K $494.0K
YoY Change 1.69% 2.13% 1.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $389.6K $389.6K $390.1K
YoY Change 1.23% -9.96% -10.36%
Total Short-Term Liabilities $1.060M $1.075M $1.056M
YoY Change 1.63% -1.37% -1.47%
LONG-TERM LIABILITIES
Long-Term Debt $158.7K $161.2K $163.3K
YoY Change -8.56% -46.72% -46.05%
Other Long-Term Liabilities $5.726K $7.480K $8.917K
YoY Change -51.3% -48.62% -38.74%
Total Long-Term Liabilities $5.726K $7.480K $8.917K
YoY Change -51.3% -48.62% -38.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.060M $1.075M $1.056M
Total Long-Term Liabilities $5.726K $7.480K $8.917K
Total Liabilities $1.225M $1.244M $1.228M
YoY Change -0.32% -11.61% -11.57%
SHAREHOLDERS EQUITY
Retained Earnings -$9.396M -$9.421M -$9.374M
YoY Change -0.59% -1.83% -2.1%
Common Stock $751.00 $751.00 $751.00
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$68.93K -$103.6K -$65.12K
YoY Change
Total Liabilities & Shareholders Equity $1.156M $1.140M $1.163M
YoY Change 8.48% 4.6% 7.18%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $25.20K -$47.84K $43.73K
YoY Change -82.56% 111.25% -36.07%
Depreciation, Depletion And Amortization $21.17K $2.330K $3.220K
YoY Change -19.84% -90.89% -87.46%
Cash From Operating Activities $7.880K -$12.89K $54.95K
YoY Change -30.14% -147.82% -49.57%
INVESTING ACTIVITIES
Capital Expenditures $69.61K $60.99K $54.85K
YoY Change -335.65% -282.55% -181.68%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$69.61K -$60.99K -$54.85K
YoY Change 135.65% 82.55% -18.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.560K -$2.542K -2.520K
YoY Change 2.81% 2.91% 2.86%
NET CHANGE
Cash From Operating Activities 7.880K -$12.89K 54.95K
Cash From Investing Activities -69.61K -$60.99K -54.85K
Cash From Financing Activities -2.560K -$2.542K -2.520K
Net Change In Cash -64.29K -$76.42K -2.420K
YoY Change 209.83% 757.0% -106.15%
FREE CASH FLOW
Cash From Operating Activities $7.880K -$12.89K $54.95K
Capital Expenditures $69.61K $60.99K $54.85K
Free Cash Flow -$61.73K -$73.88K $100.00
YoY Change -251.22% -222.38% -99.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Cash
Cash
741163 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
853 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
853 usd
CY2022Q4 us-gaap Assets
Assets
1163189 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1074904 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
161222 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
163255 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7480 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8917 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1243606 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1228311 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
751 usd
CY2023Q1 us-gaap Revenues
Revenues
511372 usd
CY2022Q1 us-gaap Revenues
Revenues
515916 usd
CY2023Q1 us-gaap Assets
Assets
1140010 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
175631 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
751 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9290829 usd
CY2022Q4 frzt Common Stock Payable
CommonStockPayable
16800 usd
CY2023Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
379825 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
379825 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
9760 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-65122 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
436278 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
526515 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10599 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
12048 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12048 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22647 usd
CY2023Q1 us-gaap Cash
Cash
664744 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
502145 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1163189 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
90237 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001485074
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75056123 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75056123 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75056123 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22870 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-54267
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
FREEZE TAG, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4532392
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
360 E 1st Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
#450
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tustin
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92780
CY2023Q1 dei City Area Code
CityAreaCode
714
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
210-3850
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75056123 shares
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17058 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16875 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7864 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13462 usd
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
431624 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
370639 usd
CY2023Q1 frzt Unearned Royalties Current
UnearnedRoyaltiesCurrent
7543 usd
CY2022Q4 frzt Unearned Royalties Current
UnearnedRoyaltiesCurrent
7543 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9373571 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
104788 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
442869 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
547657 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-36285 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
11556 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11556 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-47841 usd
CY2023Q1 frzt Weighted Average Number Of Shares Outstanding Basic1
WeightedAverageNumberOfSharesOutstandingBasic1
75056123 shares
CY2022Q1 frzt Weighted Average Number Of Shares Outstanding Basic1
WeightedAverageNumberOfSharesOutstandingBasic1
75056123 shares
CY2023Q1 frzt Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
75056123 shares
CY2022Q1 frzt Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
75056123 shares
CY2023Q1 frzt Earnings Per Sharse Basic And Diluted
EarningsPerSharseBasicAndDiluted
-0.00
CY2022Q1 frzt Earnings Per Sharse Basic And Diluted
EarningsPerSharseBasicAndDiluted
-0.00
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-303807 usd
CY2022Q1 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
9366 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22647 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-317088 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-65122 usd
CY2023Q1 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
9367 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-47841 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-103596 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-47841 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-22647 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2330 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25572 usd
CY2023Q1 frzt Imputed Interest Expense
ImputedInterestExpense
9367 usd
CY2022Q1 frzt Imputed Interest Expense
ImputedInterestExpense
9366 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
183 usd
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1728 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-5598 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3958 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11090 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17602 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2872 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2754 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3875 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12892 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26961 usd
CY2023Q1 us-gaap Payments For Software
PaymentsForSoftware
60985 usd
CY2022Q1 us-gaap Payments For Software
PaymentsForSoftware
33408 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60985 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33408 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2542 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2470 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2542 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2470 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-76419 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8917 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
741163 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
752826 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
664744 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
743909 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1500 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1500 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
162 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
234 usd
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
CY2023Q1 us-gaap Development Costs
DevelopmentCosts
431624 usd
CY2022Q1 us-gaap Development Costs
DevelopmentCosts
370639 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12892 usd
CY2023Q1 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
9367 usd
CY2022Q1 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
9366 usd
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001477932-23-003597-index-headers.html Edgar Link pending
0001477932-23-003597-index.html Edgar Link pending
0001477932-23-003597.txt Edgar Link pending
0001477932-23-003597-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
frzt-20230331.xsd Edgar Link pending
frzt_10q.htm Edgar Link pending
frzt_ex311.htm Edgar Link pending
frzt_ex312.htm Edgar Link pending
frzt_ex321.htm Edgar Link pending
frzt_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
frzt-20230331_cal.xml Edgar Link unprocessable
frzt-20230331_def.xml Edgar Link unprocessable
frzt-20230331_lab.xml Edgar Link unprocessable
frzt-20230331_pre.xml Edgar Link unprocessable
frzt_10q_htm.xml Edgar Link completed